Author: M. Monirul Azam
Abstract: This Article analyzes globalizing standard of patent protection as adopted under the TRIPS Agreement of the WTO and possible options for the Least Developed Countries (LDCs) such as Bangladesh. The Article explores possible legislative and governmental intervention options for Bangladesh utilizing the experiences of Brazil and India and to some extent South Africa while dealing with the TRIPS-compliant pharmaceutical patent issues. It also reflects on the relevant policy issues and recommendations from the World Health Organization (WHO). This Article uses legal doctrinal analysis, comparative review and field research in a LDC-Bangladesh using surveys and interviews to understand perceptions of different stakeholders regarding different policy options as available under the TRIPS agreement.